Home > Inhibitors & Agonists > Others
Cat. No. Product name CAS No.
DCC5285 Ubp646

Novel pan potentiator of GluN1/GluN2 receptors

1333213-35-6
DCC5286 Ubp684

Novel NMDAR positive allosteric modulator (PAM), robustly potentiating responses at all GluN1/GluN2 subtypes and at neuronal NMDARs

1357838-47-1
DCC5287 Ubtr008295a

Novel Antagonist of the USP5 Zinc Finger Ubiquitin-Binding Domain (USP5 ZnF-UBD)

6947-81-5
DCC5288 Ucb-11056

Modulator of cyclic AMP generation, amplifing induced cyclic AMP formation in rat brain tissue; Nootropic

127390-77-6
DCC5289 ucb30889

Potent ligand of synaptic vesicle protein 2A (SV2A)

650608-19-8
DCC5290 Ucb-6786

Novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins

537018-21-6
DCC5291 Ucb-6876

Novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins

637324-45-9
DCC5292 Ucb-fcrn-303

Novel allosteric modulator of neonatal Fc receptor (FcRn), binding to the extracellular domain of FcRn

DCC5293 uc-ddc-918013

Selective competitive inhibitor of ATX-mediated hydrolysis of the lysophospholipase substrate FS-3

313685-55-1
DCC5294 uc-ddc-931126

Selective competitive inhibitor of ATX-mediated hydrolysis of the lysophospholipase substrate FS-3

736966-32-8
DCC5295 uc-ddc-966791

Competitive dual inhibitor of the hydrolysis FS-3 and the phosphodiesterase substrate p-nitrophenyl thymidine 5'-monophosphate

485317-08-6
DCC5297 Uck2-in-135546734

Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors

DCC5298 Uck2-in-135546812

Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors

DCC5299 Uck2-in-20874830

Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors

866842-71-9
DCC5300 ucl-1972

Histamine H3 Receptor Antagonist in Treatments of Cognition Disorders

220728-17-6
DCC5301 Ucl-2190 Hydrogen Maleate

The first potent nonimidazole H3 receptor antagonist (pKi=8.40)

DCC5302 Ucm-05194

Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), Showing Efficacy in Neuropathic Pain Amelioration

2400858-74-2
DCC5303 Ucm-1336

Novel potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor, improving survival in Ras-driven acute myeloid leukemia

1621535-90-7
DCC5304 Ucm710

Dual inhibitor of fatty acid amide hydrolase (FAAH) and α/β hydrolase domain 6 (ABHD6)

213738-77-3
DCC5305 Ucn-02

Stereoisomer of UCN-01, inhibiting protein kinase C with a slightly reduced potency than UCN-01

121569-61-7
DCC5306 Ucp1172

Novel dual inhibitor of dihydrofolate reductase (DHFR) and its functional analog, Rv2671

DCC5307 Ucph-102f

Fluorescent excitatory amino acid transporter subtype 1 (EAAT1) selective inhibitor

Page 1112 / Total 1149 FirstPrevNextLastGoto